balixafortide: Clinical Trials

5 trials of balixafortide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 withdrawn. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Not yet recruiting 1, Withdrawn 1
Phase 22Completed 1, Withdrawn 1

Follow balixafortide: new trials by email Literature Review of balixafortide trials Research Report on balixafortide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma
Balixafortide, Cosibelimab - Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1Not yet recruitingArsen Osipov242026-01-012025-11-19
POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer
POL6326, Eribulin, Nab paclitaxel - Advanced Breast Cancer
Phase 1 / Phase 2WithdrawnMedSIR2022-03-162023-03-20
Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer
POL6326 - Metastatic Breast Cancer
Phase 1CompletedPolyphor Ltd.542013-06-012018-09-14
Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies
POL6326, Leukapheresis, PBSC Transplant - Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2CompletedPolyphor Ltd.382012-04-012016-02-26
Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers
POL6326 - Healthy
Phase 1CompletedPolyphor Ltd.272012-02-012015-11-25

Conditions studied

Breast Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Myeloproliferative Disorders (1)

Sponsors

Polyphor Ltd. (3)  ·  Arsen Osipov (1)  ·  MedSIR (1)

Countries

United States (3)  ·  Germany (1)  ·  Spain (1)

Top investigators

Arsen Osipov, MD (1)  ·  Daniel Couriel, M.D. (1)  ·  Halvard Boenig, M.D. Ph.D (1)  ·  Peter Kaufman, MD (1)

Results publications

PMID 28049490, PMID 29706375